Stevenage, UK based Autifony Therapeutics has been building a CNS pipeline from its expertise in ion channel drug discovery
Founder & CEO Charles Large describes the scientific foundation Autifony has built in ion channel science and how the company is leveraging it against Fragile X syndrome, orphan epilepsies, and more.